Search for: "United States v. AT&T, Inc." Results 7881 - 7900 of 8,841
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2016, 9:01 pm by Ronald D. Rotunda
” In his dissent in United States v. [read post]
11 Jan 2012, 11:39 am by Guest Blogger
  Construing a state regulation as “environmental” doesn’t insulate it from Commerce Clause review, as the town of Clarkstown, New York found out in C&A Carbone, Inc. v. [read post]
21 Jun 2018, 9:30 pm by Bobby Chen
Food and Drug Administration (FDA) issued the first of three installments of draft guidance intended to protect against “potential attacks” on the United States’ food supply. [read post]
9 Oct 2017, 4:53 pm by INFORRM
Consent to jurisdiction, which is a required element of a counter-notice under section 512(g)(3)(D), is a meaningful legal concession, and is particularly problematic for users who do not reside in the United States. [read post]
9 Mar 2012, 5:34 am by Susan Brenner
And if a grand jury does return an indictment, it then becomes the role of the courts to decide the sufficiency of the indictment, see., e.g., United States v. [read post]
31 Mar 2019, 10:38 pm by Peter Mahler
The court also rejected the plaintiff’s assertion that the so-called “Kovel privilege” (United States v Kovel, 296 F2d 918 [2d Cir 1961]) attaches to the valuation report “because the purpose of the report was not to facilitate or clarify communications between plaintiff and his attorneys. [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles)   Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
12 Apr 2012, 6:02 pm by FDABlog HPM
Palmer – Franck’s Lab Inc., a pharmacy that compounds veterinary drugs and whose bulk animal drug compounding activities were vindicated by a Florida federal district court last year, recently filed its Brief for the Appellees in the matter of United States v. [read post]